Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
about
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityIntravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence settingAdvances in HIV microbicide developmentA phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 daysFormulation, pharmacokinetics and pharmacodynamics of topical microbicides.Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria.Development of topical microbicides to prevent the sexual transmission of HIVDisruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safetyA styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.Enhancement of HIV infection by cellulose sulfate.Topical microbicides and HIV prevention in the female genital tractCorrelates of the molecular vaginal microbiota composition of African women.Non-specific microbicide product development: then and nowVaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection.Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraceptionVaginal microbicides and the prevention of HIV transmissionVaginal drug delivery systems for HIV prevention.Pharmaceutical development of microbicide drug products.HIV sexual transmission and microbicides.Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.Evaluation of Vaginal Drug Levels and Safety of a Locally Administered Glycerol Monolaurate Cream in Rhesus Macaques.Designing and developing suppository formulations for anti-HIV drug delivery.Vaginal Mucosa and Drug Delivery
P2860
Q21133918-216E2954-E4EA-4256-BD96-318745E9B56AQ21199583-A7D3966F-FE3D-4811-AFB0-BFD1B655563AQ26852858-DCD7099D-D010-48CD-844B-7523F6ACB7A7Q28743383-7D0EE05A-E772-49BE-B4B9-682425EEF447Q30412592-4CB47ADB-8CE0-4DF9-A332-33B92EA59166Q33386027-E33009A7-AF20-4B92-8691-FA5860D2991AQ33625073-DAA99C94-600F-4A90-80B5-57985FC259ADQ33880947-063B745A-473C-40E6-A7A5-11814BE26A58Q33889449-12A0C0FA-B971-40A6-B3AE-29B89B0C792DQ34080823-447FA7CB-4E5E-4962-A2F1-7D459A84E463Q34086820-2E8BB1F0-1DAD-4CF0-8545-C892EAF8D2DDQ35128707-C1827D54-8FB6-4D6C-B55D-AE07B82A4DCEQ35345283-7BE2FAC7-DAE6-4C08-B107-FED2C3505D6CQ35518190-9AE93B70-3FB4-4678-9D0C-5C98AAC50F19Q35808786-B69BA56A-2327-402B-BB04-0671D8A68AF8Q36016276-2376F182-5779-4BCC-923D-89C995A5B871Q37063819-D36CF1B8-64D3-42FD-95C0-4CB20B67293DQ37149107-102410D2-35B1-475D-AAE8-42B6F4899563Q37657468-E9D25A60-5C44-4055-B438-4BA0E28D984FQ37853935-3C19EF31-0D3B-4CB9-93BA-83D238F08109Q39063908-99B03E83-704D-47AE-96A4-0CB6FBF91A47Q40252689-5C91F241-0615-470A-B48D-9468ADF35618Q53751650-F21980A7-DE09-4376-B12C-7A3EE41F7228Q57570821-B940C08A-658A-4E2E-9866-2AA348892C7C
P2860
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
@ast
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
@en
type
label
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
@ast
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
@en
prefLabel
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
@ast
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
@en
P2093
P1433
P1476
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
@en
P2093
Clemensia Nakabiito
Florence Mirembe
Isaac M Malonza
Kamal Hazari
Lawrence O Odusoga
Lut Van Damme
Marianne Callahan
Mohamed M Ali
Olubunmi A Osinupebi
Shanta Chitlange
P304
P356
10.1097/01.AIDS.0000194797.59046.8F
P407
P577
2005-12-01T00:00:00Z